Validation of a Swiss German Language Test for Children
NCT ID: NCT06567613
Last Updated: 2026-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
180 participants
OBSERVATIONAL
2024-10-10
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usefulness of an Assistive Technology Training Program for Adolscents With Dyslexia
NCT05636813
Adaptation of Pediatric Speech Audiometry Tests Into Other Languages
NCT07156825
Benefits of Tablet-based Serious Games to Promote Speech Production in Young Children With Hearing Disabilities
NCT04454255
Efficiency of Speech and Language Intervention on Achievement of Children With Developmental Language Disorder
NCT04926311
Assessment and Remediation of Oral Disorders
NCT06046768
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Speech test
The hearing screening ensures normal hearing before enrollment. The speech reception threshold for swiss german mono- and bisyllable words is determined in an adaptive procedure.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hearing threshold better than 20dB HL at 0.5, 1, 2 and 4kHz
* Written informed consent by the parents
Exclusion Criteria
* Cognitive impairment
4 Years
6 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Basel, Switzerland
OTHER
University Hospital, Zürich
OTHER
Luzerner Kantonsspital
OTHER
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Schmid
Role: PRINCIPAL_INVESTIGATOR
Inselspital Bern, Berne University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsspital Basel
Basel, , Switzerland
Inselspital Bern
Bern, , Switzerland
Kantonsspital Luzern
Lucerne, , Switzerland
Universitätsspital Zürich
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5739
Identifier Type: OTHER
Identifier Source: secondary_id
2024-00463
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.